Lannett Company Inc (LCI.A)
LCI.A on American Stock Exchange
12.74USD
24 May 2013
12.74USD
24 May 2013
Price Change (% chg)
$0.09 (+0.71%)
$0.09 (+0.71%)
Prev Close
$12.65
$12.65
Open
$12.82
$12.82
Day's High
$12.91
$12.91
Day's Low
$12.50
$12.50
Volume
28,961
28,961
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company’s products manufactured and/or sold are prescription products. The Company’s products containing Levo are produced and marketed with 12 varying potencies. In addition... (more)
Overall
| Beta: | 0.51 |
| Market Cap (Mil.): | $365.43 |
| Shares Outstanding (Mil.): | 28.68 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| LCI.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 32.71 | 34.04 | 34.30 |
| EPS (TTM): | 0.39 | -- | -- |
| ROI: | 9.11 | 19.04 | 18.43 |
| ROE: | 9.59 | 19.78 | 19.30 |
Competitors
| Price | Change | |
|---|---|---|
| Actavis Inc (ACT.N) | $127.23 | -0.85 |
| GlaxoSmithKline plc (GSK.L) | 1,749.50p | +7.50 |
| Par Pharmaceutical Companies, Inc. (PRX.N) | -- | -- |
| Ranbaxy Laboratories Limited (RANB.NS) | Rs389.70 | -4.60 |
| Abbott Laboratories (ABT.N) | $37.76 | +0.28 |
| Mylan Inc. (MYL.OQ) | $31.18 | -0.57 |
| Forest Laboratories, Inc. (FRX.N) | $39.23 | -0.30 |
| Impax Laboratories Inc (IPXL.OQ) | $18.80 | +0.20 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 14,370.00₪ | -350.00 |
| Tyco International Ltd. (TYC.N) | $34.27 | +0.21 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

